Trade BNTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
BioNTech SE American Depositary Share (BNTX) is trading at US$93.69, down 1.64% today as of Oct 8, 09:58 EDT. The company has a market capitalisation of US$29.28B. Over the past 52 weeks, BNTX has traded between US$79.52 and US$124.00. On Syfe you can trade BNTX with $0 commission and add it to your watchlist.
| Previous close | US$95.25 |
|---|---|
| Market cap | US$29.28B |
| 52-week range | US$79.52 – US$124.00 |
| Volume | 827.7K |
| Exchange | US |
BioNTech SE American Depositary Share
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Year: 2019
Stay on top of BNTX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
